Immuron Limited (IMRN)
Nasdaq: IMRN · Pharmaceutical Preparations · Carlton, Victoria, AU · filing with the SEC since 2016
Who runs Immuron Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Lydeamore Steven George
Chief Executive Officer. First filing Apr 2026, latest Apr 29, 2026, 0 filings in all.
Officers reporting now
5
of 8 people with a filing in the last fifteen months
Directors reporting now
3
8 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Palumbo Flavio | Chief Commercial Officer | May 2026 | May 14, 2026 | none |
| Brennan Paul Gerard | Chairman of the Board | May 2026 | May 4, 2026 | none |
| Lydeamore Steven George | Chief Executive Officer | Apr 2026 | Apr 29, 2026 | none |
| Laurita Aaron James | Chief Financial Officer | Apr 2026 | Apr 29, 2026 | none |
| Kanellos Jerry | Chief Scientific Officer | Apr 2026 | Apr 29, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Pollock Daniel Jude | director | May 2026 | May 14, 2026 | none |
| Joughin Jeannette Anne | director | Apr 2026 | Apr 29, 2026 | none |
| Savarirayan Ravi | director | Apr 2026 | Apr 29, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.